Differential responses to sequential menin inhibitor therapy for acute leukemia underscore the complexities of acquired resistance

Leukemia & lymphoma/Leukemia and lymphoma 2026

View at publisher
Authors: Christopher Markosian, Conor W. Buckley, Wanxing Chai‐Ho, GJ Schiller
DOI: 10.1080/10428194.2026.2656727
Cited by: 1
References: 13

Abstract

To the Editor:The recent regulatory approval of two menin inhibitors, revumenib and ziftomenib, for treatment of relapsed and/or refractory acute leukemia has introduced a new class of targeted the...

Fields of Study & Subjects

Chemokine receptors and signaling Phagocytosis and Immune Regulation Coagulation Bradykinin Polyphosphates and Angioedema

Publication details

Journal / source
Leukemia & lymphoma/Leukemia and lymphoma
Publisher
Informa UK Limited
Volume
67
Issue
8
Pages
1845–1848
Publication date
15 April 2026
Language
EN